NPI Portal NPI Lookup & Verification

Type 1 · Individual ✓ Active NPI ✓ Valid NPI checksum

Dr. Alan P Farwell, M.D.

Endocrinology, Diabetes & Metabolism Physician in Boston, MA · enumerated 2005.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1699758151

Verified

See something wrong? Report a correction

Registry record

Entity type Individual (Type 1)
Name Dr. Alan P Farwell
Credential M.D.
Sex Male
Practice address 732 Harrison Ave, Fl 2, Preston Bldg, Boston, MA, 02118
Fax (617) 638-7449
Enumeration date Nov 29, 2005
Last updated in NPPES Dec 19, 2023

Taxonomy & licenses

207R00000X Internal Medicine Physician Allopathic & Osteopathic Physicians · License 58977 (MA) Secondary
207RE0101X Endocrinology, Diabetes & Metabolism Physician Allopathic & Osteopathic Physicians · License 58977 (MA) Primary
MD · Doctor of Medicine: A physician who completed medical school (allopathic medicine), residency training, and state licensure. About the MD credential

Other identifiers

Identifier Type State Issuer
110048364A Medicaid MA -
3120095 Medicaid NH -

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

Is NPI 1699758151 active?
Yes, as of the latest NPPES snapshot, NPI 1699758151 is active (record last updated 2023-12-19).
How do I verify Alan Farwell's NPI record?
Cross-check NPI 1699758151 against the official CMS registry at npiregistry.cms.hhs.gov. This page mirrors the same public NPPES data with a monthly snapshot.

Other providers at this practice address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2023-12-19.